GN
GNVR
Genvor Inc
$0.5100
+27.50%
No data for this timeframe.
Vol
SEC Reports1
Recent Activity
Apr 22, 2026
SEC
Genvor Inc. entered into a securities purchase agreement with Evergreen Capital Management LLC to raise up to $800,000 t
8-K — Impact 5/10
Apr 15, 2026
Insider
Pawlak Chad Lee Sr. was granted 250,000 shares
Chief Executive Officer @ $0.5000 ($125.0K)
Apr 7, 2026
Insider
Pawlak Chad Lee Sr. was granted 250,000 shares
Chief Executive Officer
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 15, 2026 | Pawlak Chad | A | $125.0K |
| Apr 7, 2026 | Pawlak Chad | A | $0.00 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
1 unique insiders with 2 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 15, 2026 | Pawlak Chad Lee Sr. | Chief Executive Officer | AWARD | 250,000 | $0.5000 | $125.0K |
| Apr 7, 2026 | Pawlak Chad Lee Sr. | Chief Executive Officer | AWARD | 250,000 | — | — |
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 5.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.